Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
WAL Western posts 69 percent Q4 2025 EPS beat shares climb 091 percent on favorable investor reaction How Antero AR earnings track against industry trends Q1 2026 EPS Misses Estimates OTEX Open Text delivers 91 percent Q1 2026 EPS beat but shares dip 081 percent in todays trading Market Wrap Tech outperforms consumer sectors as markets edge slightly lower IBIO iBio posts 778 percent year over year Q1 2026 revenue growth shares fall 607 percent on EPS miss How CryoCell CCEL performance compares to expectations 142 20260508 Is Sabra SBRA stock respecting technical levels Q1 2026 Profit Surprises NIO Inc NIO Posts Robust April 2026 Delivery Growth Crosses 11 Million Cumulative Unit Milestone Iran Conflict Oil Supply Shock and US Demand Destruction Analysis EndureAir Systems Secures 30 Crore to Scale HeavyLift Drone Capabilities Kronos Worldwide KRO Slides 407 as Selling Pressure Mounts 20260519 Inside the Fed Powell Vows He Wont Be a Shadow Chair but a Warsh Clash Will Be Tough to Avoid Rapport Therapeutics RAPP Stock Today Drops 171 Key Support at 3285 20260519 Onity Group ONIT Q1 2026 Earnings What Went Wrong and Whats Next Silver ETF Supply Under Scrutiny as India Raises Import Duties on Gold and Silver AIRelated Layoffs May Not Reliably Boost Stocks Data Suggests Asian Markets Rally on Iran Talks Optimism Nvidia Dips on Sales Outlook CC Q1 2026 Earnings Chemours Surpasses Estimates with Strong EPS Surprise Bluejay Diagnostics Inc BJDX Q4 2023 Earnings EPS Misses Estimates by a Wide Margin Amid Continued Operational Challenges RILYK Q1 2024 Earnings Negative EPS Reported as Bond Price Edges Higher PLSE Q1 2026 Earnings EPS Beat but No Revenue as Stock Declines ELTX Q1 2026 Earnings Widerthanexpected loss as clinicalstage biotech advances pipeline Horizon Quantum Holdings Surges 7 Key Levels to Watch Movado Group Surges 855 Breaking Resistance or Temporary Rally Jackson Acquisition Company II JACS Holds Steady at 1061 Amid Narrow Trading Range Oramed Pharmaceuticals ORMP Drops 89 Support Level Under Pressure